A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer

BACKGROUND: Current paradigms of anti-tumor therapies are not qualified to evacuate the malignancy ascribing to cancer stroma’s functions in accelerating tumor relapse and therapeutic resistance. Cancer-associated fibroblasts (CAFs) has been identified significantly correlated with tumor progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Qianhe, Zhang, Pengpeng, Zhang, Xiao, Feng, Yanlong, Li, Long, Lin, Haoran, Yu, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258351/
https://www.ncbi.nlm.nih.gov/pubmed/37313409
http://dx.doi.org/10.3389/fimmu.2023.1199040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258351/
https://www.ncbi.nlm.nih.gov/pubmed/37313409
http://dx.doi.org/10.3389/fimmu.2023.1199040

Ejemplares similares